Medtronic plc (MDT)
USD 80.03
(-1.65%)
USD 80.03
(-1.65%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 | 16.12 Billion USD | 9.89% |
| 2023 | 14.67 Billion USD | -6.11% |
| 2022 | 15.63 Billion USD | 6.07% |
| 2021 | 14.73 Billion USD | 3.31% |
| 2020 | 14.26 Billion USD | -3.41% |
| 2019 | 14.77 Billion USD | 1.48% |
| 2018 | 14.55 Billion USD | 3.18% |
| 2017 | 14.1 Billion USD | 2.73% |
| 2016 | 13.73 Billion USD | 46.15% |
| 2015 | 9.39 Billion USD | 19.62% |
| 2014 | 7.85 Billion USD | 2.08% |
| 2013 | 7.69 Billion USD | -2.6% |
| 2012 | 7.89 Billion USD | 12.19% |
| 2011 | 7.04 Billion USD | -9.03% |
| 2010 | 7.74 Billion USD | 12.13% |
| 2009 | 6.9 Billion USD | 15.4% |
| 2008 | 5.98 Billion USD | 10.94% |
| 2007 | 5.39 Billion USD | 12.99% |
| 2006 | 4.77 Billion USD | 14.58% |
| 2005 | 4.16 Billion USD | 14.02% |
| 2004 | 3.65 Billion USD | 17.03% |
| 2003 | 3.12 Billion USD | 19.63% |
| 2002 | 2.6 Billion USD | 1.91% |
| 2001 | 2.56 Billion USD | 10.78% |
| 2000 | 2.31 Billion USD | 20.21% |
| 1999 | 1.92 Billion USD | 61.22% |
| 1998 | 1.19 Billion USD | 2.76% |
| 1997 | 1.16 Billion USD | 11.14% |
| 1996 | 1.04 Billion USD | 19.67% |
| 1995 | 872.5 Million USD | 23.72% |
| 1994 | 705.2 Million USD | 3.31% |
| 1993 | 682.6 Million USD | 12.18% |
| 1992 | 608.5 Million USD | 14.85% |
| 1991 | 529.8 Million USD | 20.63% |
| 1990 | 439.2 Million USD | 5.17% |
| 1989 | 417.6 Million USD | 22.03% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q4 | 3.67 Billion USD | 8.97% |
| 2024 Q1 | 3.71 Billion USD | -0.64% |
| 2024 Q2 | 3.77 Billion USD | 1.81% |
| 2024 Q3 | 3.36 Billion USD | -10.85% |
| 2024 FY | 13.72 Billion USD | -6.52% |
| 2023 Q1 | 3.38 Billion USD | 0.06% |
| 2023 Q3 | 3.6 Billion USD | -0.22% |
| 2023 Q4 | 3.73 Billion USD | 3.49% |
| 2023 Q2 | 3.61 Billion USD | 7.01% |
| 2023 FY | 14.67 Billion USD | -6.11% |
| 2022 FY | 15.63 Billion USD | 6.07% |
| 2022 Q3 | 3.59 Billion USD | -3.87% |
| 2022 Q2 | 3.74 Billion USD | -16.69% |
| 2022 Q1 | 4.49 Billion USD | 16.1% |
| 2022 Q4 | 3.37 Billion USD | -6.11% |
| 2021 FY | 14.73 Billion USD | 3.31% |
| 2021 Q2 | 3.83 Billion USD | 13.88% |
| 2021 Q3 | 3.67 Billion USD | -4.12% |
| 2021 Q4 | 3.87 Billion USD | 5.36% |
| 2021 Q1 | 3.36 Billion USD | 0.45% |
| 2020 Q2 | 3.81 Billion USD | 7.47% |
| 2020 Q3 | 3.55 Billion USD | -6.71% |
| 2020 Q1 | 3.54 Billion USD | -2.29% |
| 2020 FY | 14.26 Billion USD | -3.41% |
| 2020 Q4 | 3.34 Billion USD | -5.85% |
| 2019 Q1 | 3.77 Billion USD | -0.03% |
| 2019 Q2 | 3.71 Billion USD | -1.83% |
| 2019 Q3 | 3.65 Billion USD | -1.62% |
| 2019 Q4 | 3.63 Billion USD | -0.52% |
| 2019 FY | 14.77 Billion USD | 1.48% |
| 2018 Q3 | 3.65 Billion USD | 2.64% |
| 2018 FY | 14.55 Billion USD | 3.18% |
| 2018 Q1 | 3.55 Billion USD | -0.64% |
| 2018 Q2 | 3.56 Billion USD | 0.31% |
| 2018 Q4 | 3.78 Billion USD | 3.34% |
| 2017 Q2 | 3.55 Billion USD | 1.4% |
| 2017 FY | 14.1 Billion USD | 2.73% |
| 2017 Q4 | 3.57 Billion USD | 3.32% |
| 2017 Q1 | 3.51 Billion USD | 3.33% |
| 2017 Q3 | 3.46 Billion USD | -2.75% |
| 2016 Q3 | 3.35 Billion USD | -2.1% |
| 2016 Q4 | 3.39 Billion USD | 1.22% |
| 2016 FY | 13.73 Billion USD | 46.15% |
| 2016 Q1 | 3.54 Billion USD | 5.0% |
| 2016 Q2 | 3.42 Billion USD | -3.41% |
| 2015 Q4 | 3.38 Billion USD | 71.31% |
| 2015 FY | 9.39 Billion USD | 19.62% |
| 2015 Q2 | 2.03 Billion USD | 1.19% |
| 2015 Q1 | 2 Billion USD | -2.95% |
| 2015 Q3 | 1.97 Billion USD | -2.95% |
| 2014 FY | 7.85 Billion USD | 2.08% |
| 2014 Q1 | 1.9 Billion USD | -2.56% |
| 2014 Q3 | 1.94 Billion USD | 0.88% |
| 2014 Q2 | 1.93 Billion USD | 1.31% |
| 2014 Q4 | 2.07 Billion USD | 6.26% |
| 2013 Q3 | 1.88 Billion USD | -3.59% |
| 2013 Q2 | 1.95 Billion USD | 2.25% |
| 2013 Q1 | 1.9 Billion USD | 17.84% |
| 2013 FY | 7.69 Billion USD | -2.6% |
| 2013 Q4 | 1.95 Billion USD | 3.93% |
| 2012 FY | 7.89 Billion USD | 12.19% |
| 2012 Q4 | 1.62 Billion USD | -14.78% |
| 2012 Q3 | 1.9 Billion USD | -7.0% |
| 2012 Q2 | 2.04 Billion USD | 3.44% |
| 2012 Q1 | 1.97 Billion USD | 52.12% |
| 2011 Q4 | 1.29 Billion USD | -32.73% |
| 2011 FY | 7.04 Billion USD | -9.03% |
| 2011 Q2 | 2.12 Billion USD | 20.22% |
| 2011 Q1 | 1.76 Billion USD | -5.51% |
| 2011 Q3 | 1.93 Billion USD | -9.04% |
| 2010 Q4 | 1.86 Billion USD | 11.78% |
| 2010 FY | 7.74 Billion USD | 12.13% |
| 2010 Q1 | 1.83 Billion USD | -11.74% |
| 2010 Q2 | 1.75 Billion USD | -4.47% |
| 2010 Q3 | 1.67 Billion USD | -4.57% |
| 2009 Q2 | 1.58 Billion USD | -3.23% |
| 2009 Q1 | 1.64 Billion USD | -0.18% |
| 2009 Q4 | 2.07 Billion USD | 30.36% |
| 2009 Q3 | 1.59 Billion USD | 0.31% |
| 2009 FY | 6.9 Billion USD | 15.4% |
| 2008 Q2 | 1.4 Billion USD | 0.64% |
| 2008 Q4 | 1.64 Billion USD | 7.1% |
| 2008 FY | 5.98 Billion USD | 10.94% |
| 2008 Q1 | 1.39 Billion USD | 1.01% |
| 2008 Q3 | 1.53 Billion USD | 9.32% |
| 2007 Q3 | 1.33 Billion USD | -1.84% |
| 2007 FY | 5.39 Billion USD | 12.99% |
| 2007 Q1 | 1.28 Billion USD | 1.17% |
| 2007 Q2 | 1.35 Billion USD | 5.69% |
| 2007 Q4 | 1.38 Billion USD | 3.83% |
| 2006 Q3 | 1.18 Billion USD | 0.12% |
| 2006 Q4 | 1.26 Billion USD | 7.47% |
| 2006 Q2 | 1.17 Billion USD | 2.88% |
| 2006 Q1 | 1.14 Billion USD | 3.62% |
| 2006 FY | 4.77 Billion USD | 14.58% |
| 2005 Q1 | 999.4 Million USD | -4.73% |
| 2005 Q2 | 1 Billion USD | 0.53% |
| 2005 Q3 | 1.05 Billion USD | 5.03% |
| 2005 FY | 4.16 Billion USD | 14.02% |
| 2005 Q4 | 1.1 Billion USD | 4.78% |
| 2004 Q3 | 886.4 Million USD | -6.51% |
| 2004 Q2 | 948.1 Million USD | 12.63% |
| 2004 FY | 3.65 Billion USD | 17.03% |
| 2004 Q1 | 841.8 Million USD | 0.36% |
| 2004 Q4 | 1.04 Billion USD | 18.34% |
| 2003 Q1 | 715.5 Million USD | 0.1% |
| 2003 Q4 | 838.8 Million USD | 8.25% |
| 2003 Q3 | 774.9 Million USD | -2.17% |
| 2003 Q2 | 792.1 Million USD | 10.71% |
| 2003 FY | 3.12 Billion USD | 19.63% |
| 2002 Q3 | 656.9 Million USD | 2.38% |
| 2002 FY | 2.6 Billion USD | 1.91% |
| 2002 Q4 | 714.8 Million USD | 8.81% |
| 2002 Q2 | 641.6 Million USD | 7.69% |
| 2002 Q1 | 595.8 Million USD | -12.95% |
| 2001 Q3 | 625.7 Million USD | 1.84% |
| 2001 Q2 | 614.4 Million USD | -0.65% |
| 2001 Q1 | 618.4 Million USD | -5.41% |
| 2001 FY | 2.56 Billion USD | 10.78% |
| 2001 Q4 | 684.4 Million USD | 9.38% |
| 2000 Q3 | 544.7 Million USD | -4.87% |
| 2000 Q4 | 653.8 Million USD | 20.03% |
| 2000 FY | 2.31 Billion USD | 20.21% |
| 2000 Q1 | 513.8 Million USD | -1.89% |
| 2000 Q2 | 572.6 Million USD | 11.44% |
| 1999 FY | 1.92 Billion USD | 61.22% |
| 1999 Q1 | 298.4 Million USD | -2.52% |
| 1999 Q2 | 335 Million USD | 12.27% |
| 1999 Q3 | 526.4 Million USD | 57.13% |
| 1999 Q4 | 523.7 Million USD | -0.51% |
| 1998 FY | 1.19 Billion USD | 2.76% |
| 1998 Q4 | 306.1 Million USD | 5.88% |
| 1998 Q1 | 299.6 Million USD | 3.56% |
| 1998 Q2 | 297.5 Million USD | -0.7% |
| 1998 Q3 | 289.1 Million USD | -2.82% |
| 1997 Q4 | 289.3 Million USD | 1.15% |
| 1997 Q3 | 286 Million USD | -1.0% |
| 1997 Q2 | 288.9 Million USD | -2.46% |
| 1997 Q1 | 296.2 Million USD | 5.15% |
| 1997 FY | 1.16 Billion USD | 11.14% |
| 1996 Q2 | 248.3 Million USD | -5.16% |
| 1996 Q4 | 281.7 Million USD | 12.54% |
| 1996 Q3 | 250.3 Million USD | 0.81% |
| 1996 Q1 | 261.8 Million USD | 0.42% |
| 1996 FY | 1.04 Billion USD | 19.67% |
| 1995 Q1 | 209.3 Million USD | 10.16% |
| 1995 Q2 | 199 Million USD | -4.92% |
| 1995 Q4 | 260.7 Million USD | 28.11% |
| 1995 Q3 | 203.5 Million USD | 2.26% |
| 1995 FY | 872.5 Million USD | 23.72% |
| 1994 Q2 | 166 Million USD | -9.49% |
| 1994 Q1 | 183.4 Million USD | 2.34% |
| 1994 Q3 | 165.7 Million USD | -0.18% |
| 1994 Q4 | 190 Million USD | 14.67% |
| 1994 FY | 705.2 Million USD | 3.31% |
| 1993 Q4 | 179.2 Million USD | 15.24% |
| 1993 Q3 | 155.5 Million USD | -10.68% |
| 1993 Q1 | 173.2 Million USD | -5.51% |
| 1993 Q2 | 174.1 Million USD | 0.52% |
| 1993 FY | 682.6 Million USD | 12.18% |
| 1992 Q3 | 147.2 Million USD | 4.99% |
| 1992 Q2 | 140.2 Million USD | 1.74% |
| 1992 Q1 | 137.8 Million USD | -6.95% |
| 1992 Q4 | 183.3 Million USD | 24.52% |
| 1992 FY | 608.5 Million USD | 14.85% |
| 1991 Q4 | 148.1 Million USD | 12.97% |
| 1991 Q1 | 118.8 Million USD | -2.14% |
| 1991 Q2 | 137.3 Million USD | 15.57% |
| 1991 Q3 | 131.1 Million USD | -4.52% |
| 1991 FY | 529.8 Million USD | 20.63% |
| 1990 Q4 | 121.4 Million USD | 11.27% |
| 1990 FY | 439.2 Million USD | 5.17% |
| 1990 Q3 | 109.1 Million USD | 3.81% |
| 1990 Q2 | 105.1 Million USD | -3.67% |
| 1990 Q1 | 109.1 Million USD | 117.83% |
| 1989 Q3 | -11 Million USD | 0.0% |
| 1989 Q1 | 11 Million USD | 102.1% |
| 1989 FY | 417.6 Million USD | 22.03% |
| 1989 Q2 | - USD | -100.0% |
| 1989 Q4 | -612 Million USD | -5463.64% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Abbott Laboratories | 15.71 Billion USD | -2.654% |
| Allurion Technologies Inc. | 120.57 Million USD | -13276.736% |
| Artivion, Inc. | 223.43 Million USD | -7118.687% |
| Avanos Medical, Inc. | 375.5 Million USD | -4195.34% |
| Butterfly Network, Inc. | 162.46 Million USD | -9827.616% |
| Butterfly Network, Inc. | 162.46 Million USD | -9827.616% |
| Bio-Rad Laboratories, Inc. | 1.04 Billion USD | -1439.688% |
| Boston Scientific Corporation | 7.47 Billion USD | -115.686% |
| Perspective Therapeutics, Inc. | 17.42 Million USD | -92457.099% |
| CONMED Corporation | 564.24 Million USD | -2758.525% |
| Edwards Lifesciences Corporation | 3.09 Billion USD | -421.822% |
| Paragon 28, Inc. | 210.1 Million USD | -7576.821% |
| Glaukos Corporation | 367.83 Million USD | -4284.835% |
| Globus Medical, Inc. | 887.16 Million USD | -1718.049% |
| Inspire Medical Systems, Inc. | 568.49 Million USD | -2737.145% |
| Integer Holdings Corporation | 250.95 Million USD | -6326.946% |
| Nevro Corp. | 389.36 Million USD | -4042.354% |
| Owlet, Inc. | 51.21 Million USD | -31390.267% |
| Penumbra, Inc. | 590.87 Million USD | -2629.671% |
| Vicarious Surgical Inc. | 80.66 Million USD | -19894.793% |
| Smith & Nephew plc | 3.46 Billion USD | -365.215% |
| Sonendo, Inc. | 68.46 Million USD | -23458.022% |
| STERIS plc | 1.4 Billion USD | -1051.774% |
| Stryker Corporation | 9.2 Billion USD | -75.144% |
| Vapotherm, Inc. | 66.02 Million USD | -24328.626% |
| Zimmer Biomet Holdings, Inc. | 3.27 Billion USD | -392.338% |